Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Grah, JJ; Katalinic, D; Stern-Padovan, R; Paladino, J; Santek, F; Juretic, A; Zarkovic, K; Plestina, S; Supe, M.
Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy.
World J Surg Oncol. 2013; 11(1):55-55
Doi: 10.1186/1477-7819-11-55
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Grah Josip Joachim
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Despite huge advances in medicine, glioblastoma multiforme (GBM) remains a highly lethal, fast-growing tumour that cannot be cured by currently available therapies. However, extracranial and extraneural dissemination of GBM is extremely rare, but is being recognised in different imaging studies. To date, the cause of the GBM metastatic spread still remains under discussion. It probably develops at the time of intracranial progression following a surgical procedure. According to other hypothesis, the metastases are a consequence of spontaneous tumour transdural extension or haematogenous dissemination. We present a case of a 59-year-old woman with symptomatic leptomeningeal and intramedullary metastases of GBM who has been previously surgically treated with primary subtotal resection and underwent a repeated surgery during adjuvant radiotherapy and chemotherapy with temozolomide. Today, the main goal of surgery and chemoradiotherapy is to prevent neurologic deterioration and improve health-related quality of life. With this paper, we want to present this rare entity and emphasise the importance of a multidisciplinary approach, a key function in the management of brain tumour patients. The prognosis is still very poor although prolongation of survival can be obtained. Finally, although rare, our case strongly suggests that clinicians should be familiar with the possibility of the extracranial spread of GBM because as treatment improvements provide better control of the primary tumour and improving survival, metastatic disease will be increasingly encountered.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents, Alkylating - therapeutic use
- Brain Neoplasms - pathology
- Brain Neoplasms - therapy
- Chemoradiotherapy, Adjuvant -
- Combined Modality Therapy -
- Dacarbazine - analogs & derivatives
- Dacarbazine - therapeutic use
- Female -
- Glioblastoma - pathology
- Glioblastoma - therapy
- Humans -
- Meningeal Neoplasms - secondary
- Meningeal Neoplasms - therapy
- Middle Aged -
- Muscle Weakness -
- Prognosis -
- Reoperation -
- Spinal Cord Neoplasms - secondary
- Spinal Cord Neoplasms - therapy
- Temozolomide -
- Find related publications in this database (Keywords)
- Glioblastoma multiforme
- Leptomeningeal and intramedullary metastases
- Radiochemotherapy